Your browser doesn't support javascript.
loading
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.
Di Ciaccio, Pietro; McCaughan, Georgia; Trotman, Judith; Ho, Phoebe Joy; Cheah, Chan Y; Gangatharan, Shane; Wight, Joel; Ku, Matthew; Quach, Hang; Gasiorowski, Robin; Polizzotto, Mark N; Prince, Henry Miles; Mulligan, Stephen; Tam, Constantine S; Gregory, Gareth; Hapgood, Greg; Spencer, Andrew; Dickinson, Michael; Latimer, Maya; Johnston, Anna; Armytage, Tasman; Lee, Cindy; Cochrane, Tara; Berkhahn, Leanne; Weinkove, Robert; Doocey, Richard; Harrison, Simon J; Webber, Nicholas; Lee, Hui-Peng; Chapman, Scott; Campbell, Belinda A; Gibbs, Simon D J; Hamad, Nada.
Afiliación
  • Di Ciaccio P; Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.
  • McCaughan G; University of New South Wales, Sydney, New South Wales, Australia.
  • Trotman J; Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.
  • Ho PJ; University of New South Wales, Sydney, New South Wales, Australia.
  • Cheah CY; University of Sydney, Sydney, New South Wales, Australia.
  • Gangatharan S; University of Sydney, Sydney, New South Wales, Australia.
  • Wight J; Department of Haematology, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
  • Ku M; University of Sydney, Sydney, New South Wales, Australia.
  • Quach H; Department of Haematology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
  • Gasiorowski R; Department of Haematology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
  • Polizzotto MN; Department of Haematology, Pathwest Laboratory Medicine, Perth, Western Australia, Australia.
  • Prince HM; University of Western Australia, Perth, Western Australia, Australia.
  • Mulligan S; University of Western Australia, Perth, Western Australia, Australia.
  • Tam CS; Department of Haematology, Fiona Stanley Hospital, Perth, Western Australia, Australia.
  • Gregory G; Townsville University Hospital, Townsville, Queensland, Australia.
  • Hapgood G; University of Melbourne, Melbourne, Victoria, Australia.
  • Spencer A; University of Melbourne, Melbourne, Victoria, Australia.
  • Dickinson M; Department of Haematology, St Vincent's Hospital, Melbourne, Victoria, Australia.
  • Latimer M; University of Melbourne, Melbourne, Victoria, Australia.
  • Johnston A; Department of Haematology, St Vincent's Hospital, Melbourne, Victoria, Australia.
  • Armytage T; University of Sydney, Sydney, New South Wales, Australia.
  • Lee C; Department of Haematology, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
  • Cochrane T; Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.
  • Berkhahn L; University of New South Wales, Sydney, New South Wales, Australia.
  • Weinkove R; The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
  • Doocey R; University of Melbourne, Melbourne, Victoria, Australia.
  • Harrison SJ; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Webber N; Department of Haematology, Epworth Healthcare, Melbourne, Victoria, Australia.
  • Lee HP; University of Sydney, Sydney, New South Wales, Australia.
  • Chapman S; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Campbell BA; University of Melbourne, Melbourne, Victoria, Australia.
  • Gibbs SDJ; Department of Haematology, St Vincent's Hospital, Melbourne, Victoria, Australia.
  • Hamad N; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Intern Med J ; 50(6): 667-679, 2020 06.
Article en En | MEDLINE | ID: mdl-32415723
The COVID-19 pandemic poses a unique challenge to the care of patients with haematological malignancies. Viral pneumonia is known to cause disproportionately severe disease in patients with cancer, and patients with lymphoma, myeloma and chronic lymphocytic leukaemia are likely to be at particular risk of severe disease related to COVID-19. This statement has been developed by consensus among authors from Australia and New Zealand. We aim to provide supportive guidance to clinicians making individual patient decisions during the COVID-19 pandemic, in particular during periods that access to healthcare resources may be limited. General recommendations include those to minimise patient exposure to COVID-19, including the use of telehealth, avoidance of non-essential visits and minimisation of time spent by patients in infusion suites and other clinical areas. This statement also provides recommendations where appropriate in assessing indications for therapy, reducing therapy-associated immunosuppression and reducing healthcare utilisation in patients with specific haematological malignancies during the COVID-19 pandemic. Specific decisions regarding therapy of haematological malignancies will need to be individualised, based on disease risk, risks of immunosuppression, rates of community transmission of COVID-19 and available local healthcare resources.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía Viral / Leucemia Linfocítica Crónica de Células B / Control de Infecciones / Infecciones por Coronavirus / Consenso / Pandemias / Linfoma / Mieloma Múltiple Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Intern Med J Asunto de la revista: MEDICINA INTERNA Año: 2020 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía Viral / Leucemia Linfocítica Crónica de Células B / Control de Infecciones / Infecciones por Coronavirus / Consenso / Pandemias / Linfoma / Mieloma Múltiple Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Intern Med J Asunto de la revista: MEDICINA INTERNA Año: 2020 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Australia